Beximco Pharma – Bangladeshi Pharma at a discount to local value

Tags

, , ,

Got this idea from Mello stock slam.  I quite like it, bought a just under 3% weight at 42.9 earlier in the week.

This is a Bangladeshi Generic Pharma GDR listed on AIM.  There is a substantial discount to the listed Bangladeshi co which is trading at the UK equivalent of 74p – a c40% discount to the Bangladeshi company.

There have been lots of fly-by night overseas domiciled companies on AIM.  I don’t think this is one of them.  Firstly the sector is pharma – highly sensitive and regulated – not the ideal place to operate a scam.  Secondly, the company was founded in 1974 – so it has been going quite a while.  This is one of the biggest / most liquid companies in Bangladesh.

Continue reading

Moscow Stock Exchange (MOEX)

Tags

, , , , ,

As I tweeted the other day I have just bought some Moscow Stock Exchange (MOEX). Increasingly I am tempted by low price, high quality companies in somewhat lower quality locations.

To me MOEX meets the quality bar.  It has a dominant market position being the only exchange in Russia, it has an EBITDA margin of over 70%, a net profit margin of c45%.  There hasnt been much growth in operating income over the past few years – but it doesnt really matter as this is very, very cheap.  It is trading on about twice book value and a PE of about 10. Continue reading

New Investment – Global trans

Tags

, , , , , ,

Just bought some Global Trans (GLTR.L) – 2.5% portfolio weight (I tweeted about it the other day) this is quite a nice little Russian investment.  They basically operate railway freight in Russia.  This is not without it’s risk.  But yield is very high – c16% in 2018, 2019 dividend of $1.45 (half paid already). PE is low – c5.4 for 2019.  It isn’t either that this is a company on the brink of bankruptcy either – net debt to EBITDA is c0.53 – RUB denominated, and the company has lots of railway freight assets – book value is c$4.7 per share vs a share price of c$8.7.

Continue reading

New Position – $AJOT – Asset Value Investors Japan Opportunity Trust

Tags

, ,

New position this week – AJOT.

Unusually for me this is an investment trust trading at a small premium to NAV- about a 4.5% premium.  Something of a first for me – as regular readers will know I like a trust on a discount – but I am prepared to make an exception here. It’s my first decent sized new position in a while at about a 6% portfolio weight.

Asset Value investors are a value investment firm based in London who manage British Empire securities – I covered it a while back and should have bought some. They had realised that they were doing c20% a year in Japan with their activist / deep value realisation strategy and decided to launch a fund doing the same thing, focussing on it.

Continue reading

4D Pharma ($DDDD)- Bad news but strange director buying

Quick post on 4d pharma.  I bought back in 2017 then averaged down a touch.  This hasn’t gone well, my initial stake was at £2.47 and its now c£1.00.  It’s by far the biggest of my risky holdings.  I bought in as I have various stomach health issues that are massively helped by probiotics – so there is something in this and I believe these guys are leaders who can find and develop whatever is in it. What I have is very rare – 1/10000 of the population, of those, how many invest? Of those how many would invest in this? That, is my edge, or at least my perceived edge.

This may sound like a bit of a sketchy way to invest but one I ignored was Hutchinson China Meditech – I lived in China and was convinced Chinese medicine worked.  I very nearly invested but didnt – and the price is up 37X since!

Continue reading

Porfolio Review Q1 2019

Tags

, , , , , , , , , , , , , , , , , , , , ,

Quick Portfolio Review – Q1 has been pretty poor for me – up 1.3%. vs 9% for the FTSE All share.

This is despite being up at various points.  My general policy of not runing a stop loss has hurt me.  It might be time on my more liquid holdings to consider putting stop losses in.  This is very much a function of where we are in the cycle – likely near the top / end and not a general policy.  Whilst some people would say that not having stop losses is irredemably reckless I would disagree.

Continue reading

Polski Holding Nieruchomosci $PHN – Polish Property 1/4 book

Tags

, , ,

Bought a small portfolio weight in PHN at 11.63 PLN, a 3.4% portfolio weight.  I somewhat tempered the weight as the price was a little more than I wanted to pay.  I will add if it falls back to sub 10 PLN.

I have watched this one for quite a while.  It is a Polish office developer / trust.  A stake was floated by the Polish government in 2013 at 25 PLN per share and it’s fallen ever since.  They have little debt – approximately 710m PLN liabilities vs 2748m worth of assets.  Or a book value of 41 PLN per share. Continue reading

Warsaw Stock Exchange $GPW GPW.WA

Tags

, , ,

Brief write up of the Warsaw stock exchange. I found this and think it is a rather neat idea. It is currently a 5.9% portfolio weight.

Exchanges used to be considered an typical natural monopoly – it’s inefficient to transact across multiple venues – any investor wants to be where the liquidity and best price is.  The Internet changes this, as prices can be advertised electronically  / deals can be done across multiple venues, but it still isn’t quite that simple – there are things such as settlement, regulation, risk and habit which potentially make switching exchanges difficult.

Continue reading

Fondul Proprietea raised stake + Others

Tags

, , , , , , , ,

Raised my holding in Fondul Proprietea 50%. It is now a 9% portfolio weight.

This is a Romanian investment trust trading at a discount to NAV – so very much my usual type of investment. It is managed by Franklin Templeton and is at a c45% discount to NAV (on the GDR) – very much too high given quality of management / assets and that action is being taken to narrow the discount.

It is listed on the LSE under ticker FP.  I covered it back in 2014 and have happily held it since 2012/3. Continue reading